跳至主要内容
临床试验/NL-OMON41670
NL-OMON41670已完成不适用

effect of Donor Intestinal Microbiota Infusion on residual betacell function in patients with recently diagnosed Diabetes mellitus type 1 ; the DIMID1-trial - DIMID1-trial

Academisch Medisch Centrum0 个研究点目标入组 51 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • newly diagnosed (< 6 weeks) patients with type 1 diabetes (n<=34, aged 18-39 years, BMI 20-25 kg/m2, male/females, no concomitant medication use except insulin, plasma C-peptide > 0.2 mmol/l and/or >1.2 ng/mL after MMT), fasting glucose 10-13 mmol/l and positive anti-GAD and/or anti-IA-2 titer concentrations.

排除标准

  • Use of concomitant medication including PPI and antibiotics past three months, smoking, (expected) prolonged compromised immunity (due to recent cytotoxic chemotherapy or HIV infection with a CD4 count < 240).

研究者

相似试验